S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

RSLS ReShape Lifesciences Inc

4.71

-0.29 (-5.80%)

Last Updated: 04:26:42

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more ReShape Lifesciences Charts.

ReShape Lifesciences (NASDAQ:RSLS)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more ReShape Lifesciences Charts.

ReShape Lifesciences Inc News

ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
Tuesday 14 January 2025 (1 day ago) • GlobeNewswire Inc.

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Wednesday 8 January 2025 (7 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 28 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Friday 20 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 425 - Prospectuses and communications, business combinations
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Form S-4/A - Registration of securities, business combinations: [Amend]
Friday 6 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 3 December 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 November 2024 (2 months ago) • Edgar (US Regulatory)

ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
Friday 15 November 2024 (2 months ago) • GlobeNewswire Inc.

ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
Wednesday 13 November 2024 (2 months ago) • GlobeNewswire Inc.

More ReShape Lifesciences Inc News Articles

S&P ASX 300 Metals and M...

Verizon Communications

National Australia Bank

Australian SE All Ordina...

Westpac Banking

Invesco QQQ Trust Series 1

Australia And New Zealan...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions